NLBNPIT23FA4 20250321 38000 (P23FA4) ニュース

Merck
on Thursday said its experimental treatment designed to protect infants from respiratory syncytial virus showed positive results in a mid- to late-stage trial, bringing the company one step closer to filing for approval of the shot.

The pharmaceutical giant could emerge

Tough call on Iglesias. At .225, there are only a handful of Mets starters with better averages. I mean, aside from Vientos, no Met is hitting much, so why sit Iglesias but leave Alvarez (.143, shaky D), or Taylor (.138) in the line up? I get that with Pete, Lindor, and even Nimmo, you're going to l

2s are being soaked up every time load up

😂🤣😂🤭🫱🍕

Is there any new news about this company? 

I don't think they can do that because there has not been more than couple million shares traded the last 2 months and they issue 19 million so he just did the deffered salary what they do Don't be Kamala answer the question instead of making a talking points

Knowing a subject because it's what I do.....is not the same as being "smart". No, I have no interest in trading OTC scams....so no YouTube channel, sorry.

Weird. I see Schwab with correct close figures. 

🤣😂🤣💦😥

Allow me to provide a further scientific critique of the Holcomb Energy System for the consideration of all.

https://www.youtube.com/watch?v=VtALO96nSC8

It’s all good, even if it’s a few .1/.001 less..it’s going to be a multiple run from here on🚀

🐂🐂🐂🐂🐂🐂🐂

It’s all good, even if it’s a few .1/.001 less..it’s going to be a multiple run from here on🚀

🐂🐂🐂🐂🐂🐂🐂

Have to agree with you here. It is a very strange setup going on. Why not just show everyone the JORC report they say they have. Or tell us how much these investors paid per share to get in on this deal of a lifetime. Tell us why they care about who says what on twitter or here - it's not like retai

More Voters, Especially Women, Now Say Abortion Is Their Top Issue

Donald J. Trump is shifting his stance on reproductive rights, but voters, by a wide margin, say that they trust Kamala Harris on the issue.

For women younger than 45, abortion has overtaken the economy

Yeah, they do follow the same playbook. With the occasional twist or turn....

The PGM thing is as old as mining itself. Not much imagination to try that one....but it works on the more naive investors.

They made a bad mistake with the rhodium thing though. That might

Since we have data from the Part A and the trial description says safety follow up for up to 78 days for Part A there are several possibilities.
1. The Part A completed more than 78 days ago.
2. The Part A follow up was less than the max of 78 days.
3. The Part A data was unblin

Are you saying the company's state charter does not need to be in good standing? Perhaps you can enlighten me about that. OTCMarkets.com won't play ball with a delinquent SOS as far as I am aware. I'm not familiar with the minutiae of OTCM requirements for SOS compliance, but in my experience it dee

They issued shares to themselves and sold them in the open market. They are experts in this.

Hardly a short, have been in since start of 2015. I also do not blindly support everything said by management and tout unreasonable expectations. Apparently any long that does not worship LP and LG and the big biz show must be short

What I want to hear is Missling has been replaced by a competent CEO.

The 30K was not payment.

It was a discount from the total amount that she was in the process of paying the orangeOne.

At the end of the day, she paid the total amount that appeared to be about a $25,000 discount from the amount that the orangeOne was asking for

It was not the spread it was a trade for 90,000 shares at .0026?